Navegando por Autor "Arribada, Raquel Gregorio"

Filtrar resultados informando as primeiras letras
Agora exibindo 1 - 1 de 1
  • Nenhuma Miniatura Disponível
    Item
    Sodium butyrate-loaded nanoparticles coated with chitosan for the treatment of neovascularization in age-related macular degeneration : ocular biocompatibility and antiangiogenic activity.
    (2022) Reis, Júlia Stephania dos; Teixeira, Aniely dos Reis; Quaresma, Amanda de Vasconcelos; Almeida, Tamires Cunha; Arribada, Raquel Gregorio; Neto, Julia Teixeira; Silva, Fábio Henrique Rodrigues da; Cunha Júnior, Armando da Silva; Moura, Sandra Aparecida Lima de; Silva, Glenda Nicioli da; Fialho, Sílvia Ligório; Silva, Gisele Rodrigues da
    Sodium butyrate-loaded nanoparticles coated chitosan (NaBu-loaded nanoparticles/CS) were developed to treat the choroidal neovascularization in wet age-related macular degeneration (AMD). The nanoparticles were produced by double emulsification and solvent evaporation technique, optimized by experimental statistical design, characterized by analytical methods, investigated in terms of in vitro and in vivo ocular biocompatibility, and evaluated as an antiangiogenic system in vivo. The NaBu-loaded nanoparticles/CS were 311.1 ± 3.1 nm in diameter with a 0.208 ± 0.007 polydispersity index; had a +56.3 ± 2.6 mV zeta potential; showed a 92.3 % NaBu encapsulation efficiency; and sustained the drug release over 35 days. The NaBu-loaded nanoparticles/CS showed no toxicity to human retinal pigment epithelium cells (ARPE-19 cells); was not irritant to the chorioallantoic membrane (CAM); did not interfere in the integrity of the retinal layers of rat’s eyes, as detected by the Optical Coherence Tomography and histopathology; and inhibited the angiogenesis in CAM assay. The NaBu-loaded nanoparticles/CS could be a therapeutic alternative to limit the neovascularization in AMD.